Kezar Life Sciences, Inc.·4

Jun 26, 5:22 PM ET

Dinges Jason 4

4 · Kezar Life Sciences, Inc. · Filed Jun 26, 2020

Insider Transaction Report

Form 4
Period: 2020-06-24
Dinges Jason
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-24+8,8968,896 total
    Exercise: $5.60Exp: 2030-06-23Common Stock (8,896 underlying)
Footnotes (1)
  • [F1]One-hundred percent (100%) of the shares subject to the option shall vest on 6/24/2021, subject to Reporting Person continuing to provide service through such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION